Paul Mampilly, a former hedge fund manager, American investor, and contributor to Banyan Hill Publishing, has been teasing a great medical breakthrough that is on the horizon, which could be a great investment to make. He called the breakthrough, which he has yet to reveal, something that will be more monumental that all of the medical devices, vaccinations, and drugs combined and that experts have called it a game-changer in the health industry. He also teased people that a mid-Western company is the company that will unroll what he termed the “greatest medical breakthrough in the history of mankind.” He went on to express that the method will be able to change the way that untreatable diseases are approached.
Paul Mampilly also tantalized his potential readers when he commented on the fact that the company, in question, was started up in the early 1990’s and that its CEO has been in the biotech industry as a pioneer for 25 years. People have postulated, with good reason, that the company he is eluding to is none other than Myriad Genetis (MYGN), which is a personalized medicine and diagnostics company that helps to discover cancer in people. It has been noted that the stock of the company is doing good in recent weeks and that some of the success probably has to do with the fact that it has been seeing a boost in orders for tests that reveal cancer; especially breast cancer.
If you take a look at Paul Mampilly’s StockTwits profile, you will see that he has been keying people in to good and bad stock picks for some time. He also points out companies that are very likely to disrupt their industry. If you take a look at Mampilly’s Linkedin profile, you can see that he studied at Montclair State University where he earned a Bachelor’s Degree in Finance and Accounting, and he also studied at Fordham Gabelli School of Business where he received an MBA in Finance. By browsing his profile further, you will see that he also studied Financial Engineering at New York University Polytechnic School of Engineering and studied Business Administration at State University of New York at Albany.
Paul Mampilly is a unique individual that left the world of Wall Street in order to help regular Americans to find a better life through making the right investment choices. He is a regular contributor to Banayan Hill and his newsletter, Profits Unlimited.
Paul Mampilly @ twitter.com